CGEN Stock Analysis: Buy, Sell, or Hold?
CGEN - Compugen Ltd
$1.84
-0.09 (-4.66%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 03, 2026
29d
Get Alerted When CGEN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CGEN is down 12.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CGEN is down 12.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CGEN is currently trading at $1.84, which is considered fair relative to its 30-day fair value range of $1.58 to $2.11.
Technical Outlook: Technically, CGEN is in a uptrend. The price is currently testing key support at $1.83. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.80 (+215.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CGEN is in a uptrend. The price is currently testing key support at $1.83. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.80 (+215.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.58 -
$2.11
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
Protect Your Profits
Holding CGEN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 215.2% below Wall St target ($5.80)
- WARNING: Recommendation downgraded due to -12.0% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.58 -
$2.11
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.83
Resistance Level
$2.38
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-5.63
Wall Street Target
$5.80
(+215.2%)
Revenue Growth (YoY)
-89.0%
Last updated: February 01, 2026 9:48 AM ET
Data refreshes hourly during market hours. Next update: 10:48 AM
Data refreshes hourly during market hours. Next update: 10:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGEN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$140 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$42 | 64 BUY |
Advanced CGEN Option Strategies
Professional options setups generated by AI based on today's CGEN price and gamma walls.
